TSX:WEED (Canopy Growth)
About WEED
Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.
Canopy Growth (TSX: WEED) Latest News
Investing
Can Marijuana Stocks Beat the Market This Year?
Investing
These All-Cap Dividend Stocks Have Got You Covered
Investing
Top 4 Stocks in Growing Industries
Investing
A Looming Challenge for Pot Stocks
Investing
Bearish Investors Are Betting Against Marijuana Companies
Investing
Why This Pot Stock Could Be the Best Long-Term Buy
Investing
Do You Know Which Cannabis Stocks Are Outperforming the Market?
Investing
Is Net Insider Selling a Concern for Aurora Cannabis Inc.?
Investing
Will Aurora Cannabis Inc.’s Recent Moves Make it a Market Beater With Huge Upside in 2019?
Investing
Could a U.S. Listing Propel Canopy Growth Corp. Back Above $40?
Investing
Why Canopy Growth Corp. Is the Best Pot Stock to Buy Today